ETFIQData as of Nov 19, 2026. · etfiq.com/funds/wdna

WDNA Fact Sheet: WisdomTree BioRevolution Fund

Share
$20.58
close, Nov 20, 2026

Over the year to Nov 19, 2026, WDNA returned +36.6% in total and charged 0.45% a year.

1-year total return
+33.5%
to Nov 20, 2026
Expense ratio
0.45%
a year
Net flow, 12 months to Jun 30, 2026
−$358k
monthly N-PORT basis to Jun 30, 2026

Growth of $10,000, 1 year

WDNA $13,661 +36.6% · Total return, distributions reinvested, Nov 19, 2025 to Nov 19, 2026.

Returns

WindowTotal return
1 month−12.5%
3 months−13.0%
Year to date+21.9%
1 year+33.5%
3 years+44.9%
5 years−11.8%

Total return, distributions reinvested, each window to Nov 20, 2026.

Ten largest positions

HoldingWeight
TWIST BIOSCIENCE CORP5.95%
MODERNA INC4.14%
ELI LILLY & COMPANY4.08%
JOHNSON & JOHNSON2.97%
UNITED THERAPEUTICS CORP2.45%
NATERA INC2.32%
TEMPUS AI INC2.28%
IMMUNOME INC2.26%
STRUCTURE THERAPEUTICS INC2.12%
STOKE THERAPEUTICS INC2.09%

WDNA top ten by weight, 30.7% of the fund, of its 80 equity positions, from the holdings filed for Jun 30, 2026.

Facts

Holds 80 stocks in healthcare innovation and GLP-1, 26% of its weight in S&P 500 companies · First traded Jun 3, 2021 · Benchmark Its own holdings, as of Jun 30, 2026

Source: ETFIQ, from issuer disclosures, SEC filings and exchange prices. Returns from daily closes, distributions reinvested; each number is dated beside it, and every one is on the fund’s page.Cite as: ETFIQ, WDNA Fact Sheet: WisdomTree BioRevolution Fund. Data as of Nov 19, 2026. https://etfiq.com/funds/wdna/fact-sheet/ETFIQ is an independent publisher. Not an issuer, broker or adviser. No recommendations. Printed from etfiq.com/funds/wdna.